CompletedPhase 2NCT00014599
Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva
Studying Vulvar carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Principal Investigator
- Els Witteveen, MD, PhDUMC Utrecht
- Intervention
- paclitaxel(drug)
- Enrollment
- 31 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2001
Study locations (14)
- Universitair Ziekenhuis Antwerpen, Edegem, Belgium
- U.Z. Gasthuisberg, Leuven, Belgium
- Centre Henri Becquerel, Rouen, France
- European Institute of Oncology, Milan, Italy
- Ospedale Mauriziano Umberto I, Torino, Italy
- Ospedale di Circolo e Fondazione Macchi, Varese, Italy
- Ospedale Civile, Voghera, Italy
- Academisch Medisch Centrum, Amsterdam, Netherlands
- University Medical Center Nijmegen, Nijmegen, Netherlands
- Academisch Ziekenhuis Utrecht, Utrecht, Netherlands
- Hospitais da Universidade de Coimbra (HUC), Coimbra, Portugal
- Clatterbridge Centre for Oncology NHS Trust, Merseyside, England, United Kingdom
- Oldchurch Hospital, Romford, England, United Kingdom
- Western Infirmary, Glasgow, Scotland, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00014599 on ClinicalTrials.govOther trials for Vulvar carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06447064Cancer Loyalty Card Study 2 (CLOCS-2)Imperial College London
- RECRUITINGNCT07380698The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological CancerCukurova University
- ENROLLING BY INVITATIONNANCT07023601International Prospective Multicentre Study That Evaluate the Sentinel Lymph Node Detection Rate in Patients With First Local Recurrent Scamous Cell Carcinoma of the Vulva.Hospital Universitario La Paz
- RECRUITINGPHASE2NCT05903833Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or RadiotherapyAGO Research GmbH
- RECRUITINGNANCT05576831STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide ExcisionBritish Columbia Cancer Agency
- RECRUITINGNANCT06495554Danish Vulva Cancer Recurrence StudyUniversity of Aarhus
- RECRUITINGNANCT06264167NODE (groiN ultrasOunD cancEr)Queensland Centre for Gynaecological Cancer
- ACTIVE NOT RECRUITINGNANCT06694116Charcoal Carbon Black Dye Use in Sentinel Lymph Node Mapping in Early Stage Vulvar CancerIstanbul University